Document Actions
FOR INFORMATION ON THE NEXT CHAPEL HILL DRUG CONFERENCE,
PLEASE VISIT: www.pharmacy.unc.edu/chdc.
Thank you to everyone who helped make the 2009 conference a tremendous success.
Click here to see a slideshow of photos from the event.
“The Use of Nanotechnology to Create Safe and
Effective Therapeutic and Diagnostic Products”
UNC Eshelman School of Pharmacy
The last ten years have seen a growing recognition of nanotechnology’s pharmaceutical potential and an increasing ability to turn that promise into reality. However, for nanotechnology to be successfully applied to pharmaceutics, the products must be safe and efficacious, cost effective, and able to be mass manufactured.
The Fourth Annual Chapel Hill Drug Conference, hosted by the UNC Eshelman School of Pharmacy on May 13-14, 2009, will focus on identifying the opportunities and challenges in bringing cutting-edge nanotechnology from discovery through preclinical evaluation and into human clinical studies and onward.
The event is being coordinated by the Center for Nanotechnology in Drug Delivery, UNC’s Institute for Nanomedicine, and The Carolina Partnership, an $18 million fund created by the UNC Eshelman School of Pharmacy and the University Cancer Research Fund to support the School’s research centers.
The conference will be held at the School, located in Beard and Kerr Halls on the UNC campus in Chapel Hill, North Carolina. It will begin at 5 p.m. on Wednesday, May 13, with a reception and poster session, followed by ten invited talks on Thursday, May 14, with topics covering aspects of nanotechnology including siRNA delivery, infectious diseases/vaccines, imaging and diagnostics, nanomaterials engineering, and nanotoxicology.